# Study Evaluating the Safety of Enbrel (Etanercept)

> **NCT00683384** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 93 (actual)

## Conditions studied

- Arthritis, Psoriatic

## Interventions

- **DRUG:** Etanercept (Enbrel)

## Key facts

- **NCT ID:** NCT00683384
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2010-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683384, "Study Evaluating the Safety of Enbrel (Etanercept)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00683384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*